Applications of D-Phenylalanine Methyl Ester Hydrochloride in Industrial Manufacturing

D-Phenylalanine Methyl Ester Hydrochloride serves as a critical raw material in advanced pharmaceutical synthesis, peptide production, specialty chemical manufacturing, and research development. As a direct manufacturer, we supply this compound for downstream applications that demand consistent specification, regulated input ratios, and compliance with strict industry standards. Below, we outline the principal industrial scenarios where this material delivers process-specific value, from regulated drug ingredient production lines to peptide intermediates synthesis in high-purity environments.

1. Active Pharmaceutical Ingredient (API) Intermediate Synthesis

Pharmaceutical manufacturers utilize D-Phenylalanine Methyl Ester Hydrochloride as a chiral building block in the synthesis of non-proteinogenic peptide drugs and certain β-lactam antibiotics. This intermediate enters multi-step chemical synthesis workflows requiring strict control over enantiopurity, as demanded by regulatory filings. Input ratios depend on stoichiometric requirements and targeted reaction yields, with batch records documenting each addition. This application supports the manufacture of high-value pharmaceutical actives demanded by global healthcare markets.

Industry compliance standards

• ICH Q7 GMP for Active Pharmaceutical Ingredients
• EU Regulation (EC) No 1223/2009 (where applicable)
• United States Pharmacopeia general chapter <1078> Good Manufacturing Practices for Bulk Pharmaceutical Ingredients
• Relevant Drug Master File (DMF) referencing

Typical usage ratio

• 0.25–0.65 molar equivalents, adjusted per target molecule and yield optimization; documented in validated batch formula sheets

Downstream process integration

• Introduced during early-stage condensation or amidation reactors as a protected chiral amine source; process controls include real-time enantiopurity assays and stepwise purification

Final product types

• β-lactam antibiotic intermediates
• Synthetic peptide API intermediates
• Chiral pharmaceutical compounds
• Specialty drug actives for further formulation

2. Peptide Synthesis for Research and Diagnostics

Contract peptide manufacturers and diagnostic kit producers use D-Phenylalanine Methyl Ester Hydrochloride to introduce D-configured amino residues into oligopeptides or longer chain custom peptides, which are essential for target specificity and metabolic stability in in vitro research. The compound is handled and weighed according to precise formulation protocols to ensure batch consistency and compliance with quality management systems.

Industry compliance standards

• ISO 13485:2016 for medical device and diagnostic component production
• ISO 9001:2015 for general quality management
• Synthetic peptide production guidelines (company SOPs validated by external audits)

Typical usage ratio

• 3–12% weight-to-weight per target peptide chain; optimized according to chain length and D-amino acid positioning

Downstream process integration

• Added at the protected D-residue step during solid-phase or solution-phase peptide assembly; Fmoc or Boc chemistry protocols dictate the addition point and required protection group strategies

Final product types

• Research-grade custom peptides
• Modified diagnostic peptide standards
• Stabilized isotope-labeled peptides
• Reference peptides for assay calibration

3. Chiral Fine Chemical Synthesis

Specialty chemical processors rely on D-Phenylalanine Methyl Ester Hydrochloride as a chiral auxiliary or resolving agent for the preparation of enantiomerically pure intermediates. This application requires stringent quality control and proper documentation for downstream R&D and process optimization. Integration into chemical synthesis routes allows for the manufacture of advanced intermediates used in agrochemical and fragrance development where chirality impacts performance.

Industry compliance standards

• ISO 9001:2015 certified quality management systems
• REACH Regulation (EC) No 1907/2006 for safe handling
• Company SOPs for chiral auxiliary handling and disposal

Typical usage ratio

• 5–25 mol% as a resolving agent or catalytic chiral auxiliary; exact quantity set according to the selectivity profile and resolution efficiency required

Downstream process integration

• Charged at the enantioselective synthesis or resolution stage, using either batch or continuous flow reactors; recovery and recycling protocols implemented for cost control

Final product types

• Chiral fine chemical intermediates
• Flavor and fragrance precursors with defined stereochemistry
• Enantiopure agrochemical intermediates
• Building blocks for further synthesis

4. Precursor for Modified Amino Acid Production

Manufacturers specializing in the production of non-standard amino acids for pharmaceutical, biotech, and material science segments introduce D-Phenylalanine Methyl Ester Hydrochloride as a precursor in protected or esterified forms. This controlled input is essential for downstream steps including deprotection, alkylation, or selective hydrolysis, delivering high-purity modified amino acids required in demanding R&D environments.

Industry compliance standards

• USP-NF, Ph. Eur. monographs (as relevant by target product)
• ISO 9001:2015 process validation
• Audited traceability and chain of custody protocols for material identity

Typical usage ratio

• Varies from 1.0 to 3.0 molar equivalents, determined by target conversion and downstream functionalization strategy

Downstream process integration

• Fed to selective deprotection or modification reactors as an activated ester; process monitored via HPLC or MS to verify conversion and purity at each synthetic stage

Final product types

• Non-canonical amino acids (differently protected or functionalized)
• Enantiopure amino acid derivatives
• Building blocks for subsequent peptide assembly or small molecule synthesis
• Research reagents for advanced synthetic chemistry

5. API Reference Standard Manufacturing

Reference standard producers incorporate D-Phenylalanine Methyl Ester Hydrochloride in the production of analytical and calibration materials required by pharmaceutical QC labs globally. Each batch receives traceable documentation, and precise weighing guarantees compliance with reference grade material specifications. Downstream, the compound supports method validation across chromatographic and analytical testing platforms.

Industry compliance standards

• ISO/IEC 17025:2017 accredited laboratories
• Pharmacopoeial reference standard guidelines (USP, EP, BP)
• Validated analytical reference material SOPs

Typical usage ratio

• 0.5–1.5 mg per calibration solution (analytical grade), or scaled up proportionally for bulk reference standard preparation

Downstream process integration

• Dissolved, diluted, and purified under analytical-grade conditions to ensure batch homogeneity and traceable composition; process data logged for regulatory scrutiny

Final product types

• Certified analytical reference standards
• Calibration solutions for chromatography instruments
• Pharmacopoeial reference substances
• QC lab proficiency testing materials